Drug Shortage Report for INTRON A

Last updated on 2019-08-10 History
Report ID 86790
Drug Identification Number 02238674
Brand name INTRON A
Common or Proper name interferon alfa-2b solution for injection
Company Name MERCK CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) INTERFERON ALFA-2B
Strength(s) 6000000UNIT
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1X18MIU
ATC code L03AB
ATC description IMMUNOSTIMULANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-06-18
Estimated end date 2019-08-12
Actual end date 2019-08-09
Shortage status Resolved
Updated date 2019-08-10
Company comments Limited quantities available for the 18MIU vials, but other strengths are available (10MIU & 25MIU Ready-to-Use Solution, HSA Free Vials, as well as 10MIU Powder & Diluent)
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-06-18 English Compare
v2 2019-06-18 French Compare
v3 2019-06-19 English Compare
v4 2019-07-08 English Compare
v5 2019-07-08 French Compare
v6 2019-07-26 English Compare
v7 2019-07-26 French Compare
v8 2019-08-05 English Compare
v9 2019-08-09 English Compare
v10 2019-08-09 French Compare
v11 2019-08-09 English Compare
v12 2019-08-09 French Compare
v13 2019-08-10 English Compare

Showing 1 to 13 of 13